Archive
Proactive news snapshot: Argo Blockchain, Chariot Oil & Gas, FFI Holdings...
A glance at some of the day's highlights from the Proactive Investors newswire
Company
LON:AVCT
At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets. Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.
207 stories · page 2 of 3
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The biotech company said Dr Matt Johnson would present data showing how the Affimer technology can be used to simplify diagnostics and other immunoassays
Investments and investor services
The UK blue-chip benchmark finished down nearly 139 points lower at 7,006 - not far from the 7,000 mark
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The biotechnology firm said it had been collaborating with NEB to develop Affimers to combine with NEB’s reagents (a substance used for chemical analysis)
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The junior biotech is confident it can deliver at least one “lucrative” licensing deal for its Affimer technology over the next 18 months
FTSE 100 was on the losing team all day and closed down over 21 points at 7,474
Archive
The day ahead includes full year earnings from Ferguson and Revolution Bars
Archive
The week ahead includes Tesco interims, full-year earnings from DFS Furniture and Ferguson, an Electrocomponents trading update and the US non-farm payrolls report
Archive
A look at some of the biggest risers and fallers in the UK market on Friday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Around 4pm, the UK bluechip index was 109 points higher at 7,476, just easing back from the session peak of 7,495 after a strong week
Archive
Stride Gaming was the big faller during an active week for junior stocks
The company has made solid progress with a number of partners, such as Moderna, Glythera and FIT Biotech. It has raised money to, among other things, enter into more drug development partnerships
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
It has been a good week for one of AIM's most innovative companies
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the main news-driven risers and fallers in London on Monday afternoon ...
The AIM-listed firm said Dr Trevor Nichols, who has acted as chairman of the board since January 2014, will remain on the board as non-executive director
Investments and investor services
The UK pound shed 0.38% against the Euro, while it was off 0.30% against the US dollar.
Some of the main news-driven risers and fallers in London on Tuesday afternoon...
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta has teamed up with FIT Biotech to find a way of delivering DNA treatments more effectively
The UK blue chip index closed around 18 points higher at 7,877
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Polymetal has acquired an 85% stake in one copper-gold deposit, sold an 85% in another copper-gold project, and it has also upped its stake in a silver property
The company is making progress with its lead immuno-oncology programmes
The FTSE 100 closed below the 7,200 level as sterling continues to strengthen against the dollar
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Builders and building materials
A look at some of the biggest risers and fallers in London on Thursday
Investments and investor services
Turnaround group Melrose received valid acceptances for its offer for GKN representing around 52.43% of the voting rights
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and falls on the London market today
In-vivo data will be key in securing licensing deals with large pharmaceutical companies
Investments and investor services
The FTSE 100 index – which is chock full of dollar earners – closed around 108 points lower at 7,170
Investments and investor services
Further down the food chain, Avacta, the company behind the Affirma technology - small, engineered proteins that are capable of binding specific molecular targets - got a lift from a research report by Capital Network.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at some of the day's major movers, such as Indivior, Greatland Gold, Ocado, Connect Group, Quadrise Fuels.
This time it is with OncoSec Medical, which wants to use its own gene delivery platform to deliver Avacta’s Affimers into tumour cells
“We have continued to grow the number and extent of the data packages demonstrating the power of the Affimer technology in therapeutic and non-therapeutic applications which build the commercial case and de-risk the technology for third par
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
"I am delighted with the reciprocal arrangements that we have put in place with Glythera allowing both companies to develop Affimer-Permalink drug conjugates," said Avacta's CEO, Alastair Smith
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the biggest risers and fallers in the London market on Wednesday
Investments and investor services
On a separate note, Mifid II comes into force today with the aim of increasing transparency and making everyone in the investment chain more accountable for their decisions
Archive
A look at some of the day's highlights from the Proactive Investors newswire
Some of the main news-driven risers and fallers in London on Wednesday ...
Avacta’s chief executive, Dr Alastair Smith, said the presentation provided “strong, independent validation of the technical performance of Affimer reagents and is important to our commercialisation of the technology”
Investments and investor services
Data out yesterday suggested Chinese industrial production growth is starting to slow, which is bad news for miners, but Fresnillo topped Footsie today
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Affimers are small, engineered proteins, some of which are of human origin and some plant-derived. They are capable of binding specific molecular targets, in a similar way to antibodies.
The UK blue chip index closed its account on Tuesday up 2.09 at 7,526.
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London today
The UK benchmark finished the day at 7,538, up 30.38 points
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
SSE may have rallied, but Centrica remained down in the dumps, after HSBC trimmed its price target for the British Gas owner to 190p from 202p.
Avacta chief executive, Dr Alastair Smith, said the collaboration could lead to “multiple therapeutic benefits and create a best-in-class gene therapy combination with significant potential”
The FTSE 100 rose to within a couple of points of 7,500 after US markets opened higher
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Peter Allen will not be going back to the Future board room after February's AGM
The two parts of the business - the commercial arm and research function - appear to be firing on all cylinders
Not much happening among the blue-chips but Image Scan and Future were among the big movers in the small caps sector
Archive
The day ahead includes first half numbers from supermaket giant Tesco PLC and a fourth quarter trading update from struggling tiles retailer Topps Tiles PLC
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The US Food and Drug Administration's sampling found some Listeria monocytogenes in Greencore's sandwiches
The company said the move would allow it to exploit the rapidly growing interest its Affimer alternative to antibodies
FTSE 100 closed over 66 points higher at 7,438 with budget carrier easyJet the top flyer
Archive
Week ahead to include first half results from supermarkets giant Tesco PLC, an update from high bakery chain Greggs PLC (LON:GRG), and the latest US jobs data
Archive
Some of the day's highlights from the Proactive Investors newswire
A look at some of the biggest risers and fallers in London today
Avacta said it has developed multiple PD-L1 inhibitors, which are designed to use the body's own immune system to battle cancer
The FTSE 100 index closed up 20.23 at 7,531, below the session peak of 7,533.74 and well above the day’s low of 7,511.71
Archive
Some of the day's headlines on the Proactive Investors newswire
Archive
A glance at the small cap stories on the Proactive newswire today
The deals followed technical evaluations of the technology.
The pound has given up some of its recent gains, which has helped the internationally-focused firms on the FTSE 100
Archive
A glance at the stories on the Proactive newswire today
A look at some of the biggest London-listed risers and fallers today
The principal patent protecting the Affimer technology has been accepted
The bulls could not quite push the top-share index above 7,400. Tomorrow they'll have a harder job with ex-div stocks lopping about 14 points off the Footsie
Archive
A look back at some of the week's more interesting stories from those on the junior market
Archive
A glance at some of the stories on the Proactive newswire today
A look at the top risers and fallers in London on Monday
The deal validates the licensing model, says chief executive, Dr Alastair Smith
The FTSE 100 closed 150 points, or 2.11% higher, as investors welcomed Macron's result in the first round of France's presidential election
Avacta has developed an innovative protein-scaffold platform, with potential applications in the life sciences research, diagnostic and therapeutic markets
The data, expected in the next month or so, will keep the biotech firm on track to take the first Affimer candidate into phase 1 studies, targeted for 2019
Riccardo Lowi said his sum-of-the-parts valuation for Avacta produces an equity value of £140mln, against a current market cap of around £50mln
FTSE 100 stocks bagged a net loss on Thursday after supermarket chain WM Morrison fell on an uncertain outlook
Archive
The FTSE 100-listed food retailer reported a 2.9% increase in its like-for-like sales, for the first nine weeks of the fourth quarter - its best performance in seven years.
Archive
The Chancellor of the Exchequer may have a lower debt burden to deal with than he was expecting at the time of the Autumn Statement but he is unlikely to splurge
Orders in 2016 rose by 70% as more life science company customers started to evaluate the technology
finnCap expects the group to more than double its share price within the next year as it continues to develop its Affimer PD-L1 checkpoint inhibitors
The collapse of sterling will have been a boon to both retailers
Investments and investor services
Below are some of the main news-driven share price changes at 4.15pm